MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$12,185K
Net Income
-$3,170K
Net Profit Margin
-26.02%
EPS
-$0.06
Unit: Thousand (K) dollars
Revenue Breakdown
Lab Essentials
Clinical Solutions
Other Product
Revenue Breakdown
US
Non Us
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Revenue
12,185
11,077
9,409*
10,454
Cost of sales
7,300
7,293
6,753*
7,248
Gross profit
4,885
3,784
2,656*
3,206
Research and development
554
609
513*
542
Sales and marketing
2,122
2,128
1,774*
1,747
General and administrative
4,812
5,058
5,992*
4,647
Amortization of intangible assets
287
287
287*
287
Total operating expenses
7,775
8,082
8,565*
7,223
Loss from operations
-2,890
-4,298
-5,909*
-4,017
Interest expense, net
-252
-219
-177*
-190
Other adjustment to loan exit fee
0
0
523*
0
Other income
2
9
-
-
Total other (expenses) income, net
-250
-210
345*
-190
Loss before income taxes
-3,140
-4,508
-5,564*
-4,207
Provision for income taxes
30
47
-89*
79
Net loss
-3,170
-4,555
-5,475
-4,286
Basic EPS
-0.06
-0.08
-0.102
-0.08
Diluted EPS
-0.06
-0.08
-0.102
-0.08
Basic Average Shares
53,634,826
53,606,278
53,483,503
53,516,986
Diluted Average Shares
53,634,826
53,606,278
53,483,503
53,516,986
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
Net loss
-$3,170K
(11.20%↑ Y/Y)
Lab Essentials
$9,184K
(17.86%↑ Y/Y)
Clinical Solutions
$2,428K
(17.86%↑ Y/Y)
Other Product
$573K
(31.72%↑ Y/Y)
Loss before income
taxes
-$3,140K
(11.57%↑ Y/Y)
Provision for income taxes
$30K
(57.89%↑ Y/Y)
Revenue
$12,185K
(18.45%↑ Y/Y)
Loss from operations
-$2,890K
(14.65%↑ Y/Y)
Total other
(expenses) income, net
-$250K
Gross profit
$4,885K
(22.62%↑ Y/Y)
Other income
$2K
Cost of sales
$7,300K
(15.82%↑ Y/Y)
Total operating
expenses
$7,775K
(5.50%↑ Y/Y)
Interest expense, net
-$252K
(-52.73%↓ Y/Y)
General and
administrative
$4,812K
(-2.37%↓ Y/Y)
Sales and marketing
$2,122K
(34.90%↑ Y/Y)
Research and development
$554K
(-4.65%↓ Y/Y)
Amortization of intangible
assets
$287K
(0.00%↑ Y/Y)
Buy us a coffee
Alpha Teknova, Inc. (TKNO)
Alpha Teknova, Inc. (TKNO)